Piper Jaffray reiterates their Overweight rating on shares of ARNA with a price target of $10.
http://www.streetinsider.com/Analyst+Comments/Piper+Jaffray+Says+Arena+Pharmaceuticals+%28ARNA%29+Sell-Off+is+an+%22Overreaction%22/5967972.html
Wednesday, September 15, 2010
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment